// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Impact of Living Alone on Stroke Outcomes: Results from the Registry of the Canadian Stroke Network

Jiming Fang - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Comparison of Stroke Subtype and Admission Rate between Beijing, China and Ontario, Canada - A Population-Based Approach

Gaifen Liu - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Baseline Characteristics and Functional Outcomes of Pontine and Non-pontine Infarcts: On Behalf of The Secondary Prevention of Small Subcortical Strokes (SPS3) Investigators

Jeff Szychowski - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cerebral small vessel disease

N/A

What Should Really be Happening to Our Stroke Patients Post-Acute Care?: A System Best Practice Model for Inpatient Rehab

- American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Facilitating Best Practices in Rehabilitation for Persons With Stroke: Use of a Triage Tool in Toronto

- American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Reasons for Delays in Door to Needle Time

Devika Kashyap - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Platelet-Derived Glutamate Contributes to Neuronal Injury after Experimental Subarachnoid Hemorrhage

Pitcha Chompoopong - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Subarachnoid hemorrhage

Fibrinogen (IV)

Baseline Infarct Volume Predicts Disability in TIA and Minor Stroke Patients

jonathan Coulter - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

The Acute Carotid Clinic: A Paradigmatic Shift to Facilitate Reduced Wait Times for Carotid Artery Stenting in Ontario

Airton Leonardo Manoel - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Carotid artery stenosis

N/A

Randomized Pilot Trial of Usual Care versus LIFE (Lifestyle Intervention using Functional Exercise to Reduce Falls) in Those with Mild Stroke

Lindy Clemson - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Towards Better Screening for Post Stroke Depression

Nancy Mayo - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Perinatal Stroke in the Canadian Cerebral Palsy Registry: Disease-Controlled Risk Factor Analysis

Maryam Oskoui - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cerebral Palsy

N/A

Do Aspects or Profiles of the NIHSS Predict Post Stroke Spasticity?

Heidi Sucharew - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

The Role of Lindegaard Ratio on TCD for Predicting Angiographic Vasospasm Following Aneurysmal Subarachnoid Haemorrhage

Khurshid Khan - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Subarachnoid hemorrhage

N/A

Supporting and Sustaining Systems Change Through the Development of Common Standards of Stroke Care

Jocelyne McKellar - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Clinical Integration of Stroke Services to Improve Access to Quality Stroke Care in Waterloo/Wellington Local Health Integration Network

Patti E Leonard - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Importance of Collaboration of Hospital Leaders in Implementing Stroke Best Practice Across 17 Organizations

Michelle Donald - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Increasing the Sample Size in the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial: What Did We Gain?

Jeff M Szychowksi - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

Aspirin

Applying ARISTOTLE Trial to Actual Practice

Michael Stokes - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Non-valvular atrial fibrillation

apixaban

Neurovascular Coupling is Impaired in Cerebral Amyloid Angiopathy

Cheryl R McCreary - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cerebral amyloid angiopathy

N/A

Copyright © 2026. QuantiNova All rights reserved